Liat Sorski

Liat Sorski

Auto-generated profile, based on publicly available information

Liat Sorski

Tel Aviv University, Israel

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 September 2021 in Nature Reviews Cancer
Verified
Journal Article
Closed access
PDF file
AEAnabel Eckerling
Anabel Eckerling
IRItay Ricon-Becker
Itay Ricon-Becker
LSLiat Sorski
Liat Sorski
ESElad Sandbank
Elad Sandbank
SBShamgar Ben-Eliyahu
Shamgar Ben-Eliyahu

1 September 2011 in Int. Journal of Clinical Pharmacology and Therapeutics
Verified
Journal Article
Open access
OHO. Hazut
O. Hazut
LSL. Shaashua
L. Shaashua
MBM. Benish
M. Benish
BLB. Levi
B. Levi
LSL. Sorski
L. Sorski
SBShamgar Ben-Eliyahu
Shamgar Ben-Eliyahu
Objective: COX inhibitors and b-adrenergic blockers were recently shown to reduce cancer progression in animal models through various mechanisms. These include the prevention of immune suppression during the critical perioperative period, and the preclusion of direct promoting effects of catecholamines and prostaglandins on malignant tissue growth. To assess the safety of such pharmacological treatments in the context of oncologic surgery, the current study evaluates wound healing efficacy in the skin, muscle, and colon tissues in rats undergoing colonic anastomosis. Methods: F344 rats were treated daily with a COX-2 inhibitor (etodolac), a b-adrenergic blocker (propranolol), both drugs or vehicles. All rats underwent skin punch biopsy, and half were also subjected to laparotomy and colonic anastomosis. Tensile strength of the abdominal wall and colonic bursting pressure were assessed on Days 3, 7, and 30 postoperatively, and skin biopsy site healing was scored on Days 2, 4, and 6 postoperatively. Results: None of the drug treatments produced any deleterious effects along the expected course of tissue healing. On Day 30, colon bursting pressure showed an abnormal strengthening in animals undergoing anastomosis compared to non-operated animals, across all drug treatments. This abnormal strengthening was attenuated by etodolac. In the skin, surgery reduced healing rate, irrespective of drug treatments. Conclusions: Effective doses of etodolac and propranolol caused no negative effects on wound healing processes in rats. The apparent safety of such treatments, together with their potential clinical benefits, suggests the incorporation of these treatments in oncologic patients undergoing curative tumor resection.

1 August 2010 in Brain, Behavior, and Immunity
Verified
Journal Article
Closed access
SBShamgar Ben-Eliyahu
Shamgar Ben-Eliyahu
ERE. Rosenne
E. Rosenne
LSL. Sorski
L. Sorski
BLB. Levi
B. Levi


21 November 2022 in Brain, Behavior, and Immunity
Verified
Journal Article
Closed access
ESElad Sandbank
Elad Sandbank
AEAnabel Ekerling
Anabel Ekerling
LSLiat Sorski
Liat Sorski
SCSteve Cole
Steve Cole
SBShamgar Ben-Eliyahu
Shamgar Ben-Eliyahu